WO2022112460A1 - Système et dispositif pour caractériser des changements dans le processus de maturation d'un ovocyte, et leur utilisation - Google Patents
Système et dispositif pour caractériser des changements dans le processus de maturation d'un ovocyte, et leur utilisation Download PDFInfo
- Publication number
- WO2022112460A1 WO2022112460A1 PCT/EP2021/083078 EP2021083078W WO2022112460A1 WO 2022112460 A1 WO2022112460 A1 WO 2022112460A1 EP 2021083078 W EP2021083078 W EP 2021083078W WO 2022112460 A1 WO2022112460 A1 WO 2022112460A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrodes
- depression
- egg cell
- complex resistance
- oocyte
- Prior art date
Links
- 210000000287 oocyte Anatomy 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000008569 process Effects 0.000 title claims abstract description 21
- 230000035800 maturation Effects 0.000 title claims abstract description 17
- 239000000758 substrate Substances 0.000 claims abstract description 20
- 230000032823 cell division Effects 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 96
- 230000004720 fertilization Effects 0.000 claims description 35
- 238000005259 measurement Methods 0.000 claims description 27
- 239000012530 fluid Substances 0.000 claims description 15
- 238000012512 characterization method Methods 0.000 claims description 5
- 238000002847 impedance measurement Methods 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 229940124558 contraceptive agent Drugs 0.000 claims description 3
- 239000003433 contraceptive agent Substances 0.000 claims description 3
- 238000010586 diagram Methods 0.000 claims description 3
- 229920001940 conductive polymer Polymers 0.000 claims description 2
- 230000000877 morphologic effect Effects 0.000 claims description 2
- 239000002861 polymer material Substances 0.000 claims 1
- 210000004340 zona pellucida Anatomy 0.000 description 26
- 210000001161 mammalian embryo Anatomy 0.000 description 21
- 238000000157 electrochemical-induced impedance spectroscopy Methods 0.000 description 16
- 210000002257 embryonic structure Anatomy 0.000 description 14
- 238000007373 indentation Methods 0.000 description 11
- 230000009027 insemination Effects 0.000 description 10
- 238000001228 spectrum Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000010355 oscillation Effects 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 102100031204 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 Human genes 0.000 description 4
- 101001129086 Homo sapiens 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 Proteins 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000013020 embryo development Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- 229920000144 PEDOT:PSS Polymers 0.000 description 2
- 229920001486 SU-8 photoresist Polymers 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000002459 blastocyst Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000000763 evoking effect Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001566 impedance spectroscopy Methods 0.000 description 2
- 238000001453 impedance spectrum Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000011810 insulating material Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008182 oocyte development Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 229920002120 photoresistant polymer Polymers 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000128 polypyrrole Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000004017 vitrification Methods 0.000 description 2
- BKZOUCVNTCLNFF-IGXZVFLKSA-N (2s)-2-[(2r,3r,4s,5r,6s)-2-hydroxy-6-[(1s)-1-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-[(2r,3s,4r,5r)-5-[(2s,3s,4s,5r,6s)-6-hydroxy-4-methoxy-3,5,6-trimethyloxan-2-yl]-4-methoxy-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-7-methoxy-2,8-dimethyl-1,10-dioxaspiro[4.5]dec Chemical compound O([C@@H]1[C@@H]2O[C@H]([C@@H](C)[C@H]2OC)[C@@]2(C)O[C@H](CC2)[C@@]2(C)O[C@]3(O[C@@H]([C@H](C)[C@@H](OC)C3)[C@@H](C)[C@@H]3[C@@H]([C@H](OC)[C@@H](C)[C@](O)([C@H](C)C(O)=O)O3)C)CC2)[C@](C)(O)[C@H](C)[C@@H](OC)[C@@H]1C BKZOUCVNTCLNFF-IGXZVFLKSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- BKZOUCVNTCLNFF-UHFFFAOYSA-N Lonomycin Natural products COC1C(C)C(C2(C)OC(CC2)C2(C)OC3(OC(C(C)C(OC)C3)C(C)C3C(C(OC)C(C)C(O)(C(C)C(O)=O)O3)C)CC2)OC1C1OC(C)(O)C(C)C(OC)C1C BKZOUCVNTCLNFF-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 208000034702 Multiple pregnancies Diseases 0.000 description 1
- 101100256746 Mus musculus Setdb1 gene Proteins 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000000339 bright-field microscopy Methods 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910000457 iridium oxide Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000472 morula Anatomy 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229960002796 polystyrene sulfonate Drugs 0.000 description 1
- 239000011970 polystyrene sulfonate Substances 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/06—Bioreactors or fermenters specially adapted for specific uses for in vitro fertilization
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
Definitions
- the invention relates to a device for characterizing changes in the maturation process of an egg cell.
- the invention also relates to a system with the inventive device and its use.
- the artificial insemination of egg cells is an established method in reproductive medicine.
- ZP zona pellucida
- the oocyte and embryo quality is typically assessed through a microscopic control.
- the microscopic control is strongly dependent on the experience and the ability and knowledge of the assessing person, ie the assessment is highly subjective.
- the morphological assessment of the oocyte immediately before fertilization is highly subjective and can only be performed by experienced embryologists. This is described, for example, in the article "The Istanbul consensus workshop on embryo assessment", in Human Reproduction, Vol.26, No.6 pp. 1270-1283, 2011.
- the quality is generally only assessed again 18 hours after fertilization.
- a microfluidic device for receiving cells is known from the prior art according to WO2012/094956 A1, with the aid of which it should be possible to determine the cell size.
- time-lapse procedure assesses the embryo, i.e. the egg cell, only after fertilization and can therefore only be used to a limited extent for ethical reasons under German legislation. In addition, this is a very expensive process, so it is rarely used.
- PES pre-implantation genetic screening
- embryo protection laws apply. According to a conservative interpretation, for ethical reasons only the egg cells in the pronuclear stage (18 hours after fertilization) can be evaluated and selected. This means that at this point in time a decision must already be made as to which egg cells (usually 2 - 3) are to be cultivated further up to day 3 - 5 and finally transferred back into the uterus (usually 1 - 2 embryos). This is to avoid storing embryos.
- the other oocytes (on average 5-10 oocytes are obtained per woman after hormonal stimulation) are frozen in the pronuclear stage.
- the process of vitrification involves risks that reduce the quality of the oocytes (not all oocytes that were of good quality before vitrification still have them afterwards). Reliable quality control of the fertilized egg cell would therefore be particularly important.
- the aim here is to transfer only one embryo, namely the one with the best chance of a successful pregnancy and to avoid the risks of multiple pregnancies.
- the remaining embryos are frozen or discarded. According to the Embryo Protection Act, this is not permitted in Germany.
- the great divergence of the legal framework conditions shows the enormous importance of reliable egg cell and embryo control.
- the invention is explained in more detail below with reference to a drawing and exemplary embodiments.
- the drawing is a schematic representation and not to scale. The drawing does not limit the invention in any way.
- Fig. 1 shows the relationship between zona pellucida hardness and oocyte or embryo development over time
- Figures 2a and 2b show a schematic view of a device according to embodiments of the invention
- FIG. 3a, 3b & 3c each a schematic view of a device according to embodiments of the invention with an oocyte
- FIG. 4 a further schematic view with further aspects of a device according to embodiments of the invention
- FIG. 5 is a further schematic view showing further aspects of a device according to embodiments of the invention with an oocyte.
- a device according to embodiments of the invention with an oocyte.
- FIG. 5 is a further schematic view showing further aspects of a device according to embodiments of the invention with an oocyte.
- Detailed presentation of the invention In the following, the invention is presented in more detail with reference to the figures. It should be noted that different aspects are described, which can be used individually or in combination. That is, each aspect can be used with different embodiments of the invention, unless explicitly presented as a pure alternative.
- Figure 1 shows the relationship between zona pellucida hardness and oocyte or embryo development over time.
- time axis reference is made to the state before fertilization as well as after fertilization and the cell division taking place up to the so-called blastocyst.
- ovum is understood to mean not only the ovum per se, but also the maturation of an embryo up to the blastocyst stage, but in particular up to the morula, and further in particular up to the multinucleate stage.
- the invention describes a device for evaluating egg cells Ez used for artificial insemination.
- the device for characterizing changes in the maturation process of an egg cell Ez has a substrate S. At least one recess V is provided on the substrate S for receiving an egg cell Ez. Such devices are shown schematically in Figures 2a, 3a and 4.
- At least two electrodes are provided in the edge regions of the recess V.
- the edge area is also to be understood as lying in the depression V.
- Electrodes El, E2 are provided in Figures 2a, 2b, 3a and 3b, and four electrodes Ela, Elb, E2a, E2b are provided in Figures 4 and 5.
- the exact number/arrangement and connection of the electrodes can be suitably selected by a person skilled in the art.
- the electrodes are preferably arranged in pairs symmetrically to one another.
- the electrodes preferably have a similar design in the edge region of the depression V, at least with respect to the depression V.
- the electrodes can be suitably contacted for electrical control and measurement. In the illustrations, this is provided via the contact surface that is led outwards. Even if the feed to the contact surfaces and the contact surfaces themselves are shown as being of the same type, this is not a necessity for the functioning of the invention.
- a complex resistance Z of the egg cell can be measured during operation, with a first complex resistance Zi being able to be measured at a first point in time ti and with a second complex resistance Z 2 being measured at a second point in time t 2 , which follows at the first time ti can be measured.
- the degree of maturity or the progress of the cell division of the egg cell Ez can be inferred from the deviation of the real and/or imaginary part and/or amount of the measured first complex resistance Zi and second complex resistance Z 2 .
- the real part can change differently from the imaginary part, so that the degree of maturity or the progress of cell division of the egg cell Ez can be inferred from the qualitative and/or quantitative change in the real part and/or imaginary part and/or the amount for the respective type of egg cell .
- Measurements of the complex resistance can be made periodically, for example, based on a previously measured complex resistance or the change in previous complex resistances. This can be dependent on the use of the device, for example.
- the electrodes can be connected to an impedance spectrometer, an LCR measuring bridge or a vector network analyzer, for example, in order to measure the complex electrical resistance as a function of the applied frequency - also referred to as electrical impedance.
- EIS electrical impedance spectroscopy
- DS dielectric spectroscopy
- Measurements over a large frequency range can be used to study impedance changes caused by changes in the ZP glycoprotein matrix as well as electrophysiological changes in the cytoplasm.
- the device combines ease of use, miniaturization, integration and portability.
- EIS also allows continuous and non-destructive live observation and characterization of maturing cells and developing embryos.
- the artificial insemination of egg cells is an established method of assisted reproduction (ART) in humans and animals.
- Artificial insemination means in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). It is routinely used when natural mating fails, or when livestock and research mammals are to be cloned and reproduced.
- Artificial insemination is critically dependent on the quality of the oocytes, particularly the condition of the ZP, a gelatinous outer layer of extracellular matrix that spontaneously hardens and becomes impenetrable to sperm during oocyte isolation and culture.
- ZP2 zona pellucida protein 2
- oocyte electrophysiology is induced by sperm PLCzeta.
- cytoplasmic Ca 2+ oscillations are evoked during the activation of the egg cell.
- this physiological activation can be triggered artificially, for example by lonomycin or PLCzeta treatment.
- the Ca 2+ oscillations induced by the PLCzeta can be regarded as a quality benchmark for the activation of the egg cells.
- the characteristic Ca 2+ waves can now also be detected by the invention using electrical impedance spectroscopy with the devices of the invention.
- Zn 2+ secretions that occur in the oocytes after fertilization have been detected by Zn 2+ imaging.
- Zn 2+ releases can also be detected using electrical impedance spectroscopy with the devices of the invention.
- the current is split between displacement current in the dielectric boundary and conduction current in the extracellular shunt path.
- the current translocated across the membrane includes, for example, capacitance contributions from the passive permittivity of the lipid membrane, mobile charges associated with membrane proteins, and excitable contributions associated with the membrane's voltage-gated ion channel kinetics. Charges and dipoles are detected in the ZP. Measurements in this frequency range can therefore be used to estimate the effective impedance (dielectric) of the cell membrane and the ZP.
- Impedance measurements generated from measuring the cell with even higher frequency signals can be used to study intracellular effects. In this frequency range, the cell membrane and ZP become transparent. Intracellular charge distributions such as intracellular Ca 2+ ion oscillations after the fertilization of egg cells can be measured from the impedance spectra. The exact frequencies at which maximum impedance signal changes and thus signal sensitivities can be determined depend heavily on the cell type used, the structure and the configuration of the structure, the electrode surface and its material.
- EIS has so far been a measurement method for the short-term characterization of dielectric properties and sizes of individual cells in high-throughput applications, such as in cytometry or cell sorting/flow cytometers.
- the present invention is designed for long-term observation periods.
- the electrodes e.g. four microelectrodes, can be located in the depression V or at its edge.
- the electrodes can be used to measure the dielectric properties of cells.
- the size of electrodes depends on the design of the cavity V, the size of the oocyte Ez and the fill factor to be achieved.
- the fill factor i.e. the quotient of the volume of the cell and the measurement volume, can be adjusted with the design of the electrodes and the cavity.
- the device has, for example, a kind of holding device made of a planar, preferably transparent (carrier) substrate S.
- the substrate S can be glass or a transparent polymer, for example.
- At least one insulating layer ZS1 or ZS2 is applied to the substrate S. Suitable materials can also be plastics such as polymers or paints.
- the intermediate layer ZS1 or ZS2 can also be made from the same material as the substrate S.
- the intermediate layer ZS1 can also be made from a photoresist such as SU-8. At least one depression V for receiving a single egg cell Ez can be arranged in this intermediate layer ZS1.
- the device or parts thereof can also be manufactured using other techniques.
- parts can also be produced by injection molding or with RAD-based processes such as 3D printers.
- substrates S and/or intermediate layers ZS1, ZS2 can be produced in this way.
- substrates S and/or intermediate layers ZS1, ZS2 can be produced in this way.
- metallic Elements such as electrodes E1, E2; Ela, E2a, Elb, E2b, imprint or apply by other methods.
- the choice of manufacturing process can be determined by the number used and/or by the sizes required.
- the size of the depression can also be larger than the egg cell. Then the egg cell lies in the depression (top view according to Figure 3a / 3b).
- the shape of the indentation V (in top view according to Figure 2b / 3b) is not necessarily round, but can also be (poly)angular. The only important thing is that the egg cell can lie in the recess V at least at the edge, so that there is spatial fixation in relation to the electrodes. It is not absolutely necessary that the egg cell Ez is smaller than the diameter of the indentation V, but the egg cell Ez can also rest on the edge of the indentation V - as shown in Figure 3c - and thus only with a partial area in the indentation V protrude.
- the diameter of the depression V for fixing the egg cells is preferably about 30 - 70 ⁇ m, e.g. for mouse egg cells.
- a non-round indentation V exposes areas at the top edge of the indentation V where the field lines are conducted through the conductive medium surrounding the cell without cell contact. This reduces the measuring signal level and thus the sensitivity.
- the diameter of the indentation V is preferably smaller than the diameter of the oocyte.
- the oocyte then lies on the upper edge of the indentation V and covers (mostly or completely) the indentations V. For a high to maximum impedance signal level, a close contact of the oocyte Ez to the edge of the indentations V is preferred, so that all electric field lines are forced through the oocyte will.
- an outlet opening to a fluid channel can be located in the bottom area of the depression.
- the diameter of the opening in the recess is preferably smaller than the diameter of the recess V and the egg cell Ez.
- This can be used, for example, as a control for the introduction of an egg cell Ez, in order to control a fluid flow, for example by means of a pressure difference, in an associated fluid channel FK .
- This can be advantageous, for example, when the egg cell Ez to be observed does not sink into the depression V of its own accord, for example it is floating in a cell medium.
- By generating negative pressure behind the opening nutrient medium can be drawn off into the depression V and through the fluid channel.
- the egg cell can be hydrodynamically positioned and fixed in the depression after it has been placed in a nutrient solution (hydrodynamic trap).
- a nutrient solution hydrodynamic trap
- an inflow can be generated by reversing the fluid flow and thus (specifically) the egg cell can be released from the cavity.
- An exemplary nutrient solution is, for example, EmbryoMax® Advanced KSOM Embryo Medium, as is available, for example, from Sigma-Aldrich Chemie GmbH, Taufkirchen. However, this does not explicitly exclude other nutrient solutions.
- the fluid channel can allow fluid to flow out of the depression (to fix the egg cell in the depression) and/or fluid can flow in (e.g. release the egg cell from depression V). to allow.
- At least one electrode E1 or E1b, E2b is attached in the shown embodiments, which is preferably ring-shaped in the case of a round depression V, see Figures 2b, 3b and 5.
- At least one further electrode E2 is applied on the bottom of the depression V, in the embodiments in FIGS. 4 and 5 in the area of the opening.
- An AC voltage at different frequencies can be applied between (pairs of) electrodes, the current flow can be measured and the impedance can be calculated from this.
- Figures 2b, 3b and 4 show advantageous exemplary embodiments of the electrodes. The exact layout and placement of the electrodes depends on the application.
- the individual electrodes are contacted with one or preferably with two leads in order to enable 2-point or preferably 4-point measurements.
- Figures 2b, 3b and 5 each show an example of a lead to an electrode.
- the leads can be electrically isolated with an insulating material. Preferably the insulating material is transparent.
- measurements with 3 electrodes can also be carried out, in which the third electrode is designed as a reference electrode, e.g. made of silver/silver chloride. Other suitable materials can also be used.
- Photoresists are preferably used for the insulating layers, preferably the SU-8 photoresist is suitable, which is also applied to the carrier substrate in thick layers in the normal process (in liquid form by spin-on and then drying) or as a dry film resist (by lamination) and with lithographic processes can be exposed and structured.
- the electrodes and the Leads preferably consist of precious metals such as gold or platinum or oxidic semiconductors such as iridium oxide and are deposited using PVD methods (evaporation, cathode sputtering) and structured using lithographic methods in combination with lift-off techniques or etching techniques. It is also possible to use transparent electrodes, for example made from an oxidic semiconductor, such as indium tin oxide (ITO) electrodes, in order to enable optical access to the egg cell from the underside in combination with a transparent carrier substrate.
- the leads are preferably made of conductive material with a low ohmic resistance. Other suitable materials and fabrication processes, such as precision engineering or the fabrication of leads and electrodes by modified inkjet printing on substrates, can also be used, adapted to the size of the cells to be examined.
- the electrodes can be modified to minimize their capacitive influence on the electrical double layer in the low frequency range. This capacitive behavior (and thus the limit frequency) can be shifted to the lower frequency range by increasing the effective electrode area.
- the electrodes can advantageously be achieved by potentiostatic deposition of conductive polymers, e.g. polypyrrole polystyrene sulfonate (PPy:PSS), poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS), polyaniline or mixtures thereof (the process is called electropolymerization). These layers are porous and thus increase the effective electrode area.
- electrodes are porous, they have a higher effective electrode area compared to the footprint.
- Transparent layers are advantageous for the embodiments in which optical access to the egg cell is provided from the bottom of the depression (transmitted light microscopy).
- the one surrounding barrier B has at least one depression. Since the barrier B can be optically opaque, it can also be made from a different material than the substrate S or the intermediate layer ZS1, ZS2.
- the degree of maturity can also be assessed by means of optical systems (in reflected light or transmitted light operation) as an alternative or in addition to an impedance measurement.
- the device according to the invention can also have control electronics for selecting specific pairs of electrodes for targeted measurements on a number of egg cells have a specific egg cell.
- This can, for example, connect a measuring device to the respective electrodes by means of a switch.
- Exemplary switches include, but are not limited to, electronic switches (eg, transistors) or electrical switches (DIP switches).
- the control can advantageously be designed as a multiplexer.
- the control electronics can be provided on a printed circuit board, for example.
- An impedance spectrometer or an LCR measuring bridge or a vector network analyzer as well as a PC can be connected via suitable connections and cables as an example for recording, storing and processing measured values.
- an impedance spectrometer or an LCR measuring bridge or a vector network analyzer is implemented on the control electronics, so that an integrated and mobile system can be made available.
- the device combines ease of use, miniaturization, integration and portability. EIS also allows continuous monitoring of maturing cells and developing embryos.
- the device is preferably placed in an incubator or in a temperature cabinet in order to keep the medium and the egg cells at a constant temperature of preferably 37° C. for the measurements.
- a cover plate can be provided which can be placed on the barrier.
- the device can also have a temperature control unit.
- the barrier B can be made of a metallic material, such as aluminum, and one or more controllable heating elements, which keep the medium, including the oocytes, regulated at a predetermined temperature, preferably 37°C for human oocytes.
- a temperature sensor can measure the temperature in the nutrient solution/medium and thus enables the predetermined temperature to be controlled using a suitable control device.
- a heating element can be immersed in the nutrient solution or thin-film resistors can be arranged on the bottom of the carrier substrate in the area of the depression(s) V.
- the device can have a unit for atmospheric control.
- the device can also be flown over with a gas, such as gas mixtures containing CCk (eg, preferably 5% CO), or it can be located in a closed atmosphere.
- a gas such as gas mixtures containing CCk (eg, preferably 5% CO)
- the interior of the barrier B can be filled with nutrient solution, brought to the desired operating temperature of preferably 37° C., and egg cells Ez placed in the wells V.
- the electrical impedance spectrum (real and imaginary part, phase) of a well V filled with an egg cell Ez is measured over the entire frequency range, for example 1 Hz to 1 MHz.
- the absolute values of the impedance can also be determined over the frequency.
- This spectrum is subtracted from a spectrum, called the reference spectrum, which is recorded simultaneously from another well V without an oocyte.
- parasitic effects in particular polarization effects of the electrodes and influences of the leads, are filtered out.
- Cell-specific changes can be deduced from the difference in the spectra and the frequency of the highest sensitivity can be determined, which is advantageously used for further measurements.
- a reference spectrum of an empty well V is recorded, then the egg cell Ez is placed in this well V and the impedance is recorded again.
- the frequency with the highest sensitivity is determined.
- the magnitudes of the impedance signals of both spectra can be subtracted from one another.
- cell-specific changes can be deduced from the difference in the spectra.
- the device In a typical measurement routine, the device is used, oocytes Ez are placed in the (respective) well V of the holding device, temperature-controlled and the electrical impedance is recorded as a function of time at the frequency of the highest sensitivity. According to the invention, changes in the maturation process of an egg cell are analyzed with the impedance measurements.
- a local minimum can be expected to occur, for example, when a (pre-)determined slope is reached, so that the time window does not necessarily begin with the local minimum, but can also include it.
- Sperm can be added directly to the cell medium for fertilization.
- a supply to an entire medium for a large number of egg cells Ez for example in an arrangement for several egg cells Ez
- a supply to individual compartments can be provided.
- fertilize an oocyte in a targeted manner by means of an intracytoplasmic sperm injection.
- the impedance changes, e.g. the impedance increases again.
- the measurement period can range from a few minutes, e.g. 20 minutes, to hours and even days.
- Physiological phenomena such as the release of Zn 2+ and Ca 2+ ions occur immediately or with a time delay after fertilization.
- the impedance can preferably be measured at the frequency with the highest sensitivity and high sampling rate, typically one measurement per second, over a period of 60 minutes after insemination in the device described here.
- Oscillations in the ElS signal can be resolved that can be associated with characteristic voltage-gated ion channel kinetics in the membrane evoked by characteristic sperm PLCzeta-induced Ca 2+ oscillations in the cytoplasm and the release of Zn +2 ions.
- the device is redesigned for high-frequency measurements.
- a vector network analyzer with an intermediate 50 W matching network is preferably connected here.
- the device characterizes individual oocytes by electrical impedance spectroscopy to assess oocyte quality and potential for fertilization and embryo development.
- the device measures non-destructively and enables label-free long-term measurements over the entire period of artificial insemination.
- the oocytes can be placed in the device, removed and exchanged easily and quickly. By resting on the edge of the depression V, changes in the size of the cells can be compensated for.
- Time-resolved EIS measurements make it possible to measure changes in ZP as well as the electrophysiological processes of the oocyte. Inspection by (inverse) microscopy allows measurement of oocyte diameter as well as ZP layer thickness during ZP maturation and hardening.
- the parallel and thus time-saving characterization of several oocytes is an added value.
- egg cells of different qualities can be assessed in the screening process. Only the egg cells with good development, i.e. maturation potential, are selected for fertilization. This significantly increases the chances of success.
- the device can be used for all types of oocyte evaluation and breeding programs with limited oocyte availability and will thus improve results in assisted reproduction.
- the oocytes/embryos of the best quality are preferably selected.
- the fertilization success can be increased by determining the optimal fertilization times, and thereby the development potential of the embryo.
- the chance of a successful pregnancy increases and the risk of further necessary interventions decreases.
- determining the best egg cell/embryo quality can lead to a reduction in the number of animals to be used. By increasing the fertilization rate of an individual animal, fewer female animals need to be used for egg cell retrieval.
- the fertilization of the egg cell must be optimized. Oocytes and sperm are often only available in reduced quantities. With the help of the device, the egg cells/embryos of the best quality can be determined and thus the success of a successful pregnancy can be increased.
- the device according to the invention can also be used in a system for characterizing contraceptives.
- Contraceptives can, for example, act in such a way that the ZP is changed by the influence of substances in such a way that fertilization becomes impossible for predetermined periods of time.
- both an egg cell in the device can be exposed to such a substance and its effectiveness can be tested directly by subsequently adding sperm cells to the medium.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Electromagnetism (AREA)
- Cell Biology (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne un dispositif de caractérisation de changements du processus de maturation d'un ovocyte (Ez), comprenant les éléments suivants : un substrat (S) ; au moins une dépression (V) pour recevoir un ovocyte (Ez) étant prévue dans le substrat (S), comprenant : au moins deux électrodes (E1, E2 ; E1a, E1b, E2a, E2b) étant prévues dans les zones de bord de la dépression (V) ; une résistance complexe (Z) de l'ovocyte (Ez) pouvant être mesurée pendant le fonctionnement au moyen des électrodes (E1, E2 ; E1a, E1b, E2a, E2b), une première résistance complexe (Z1) pouvant être mesurée à un premier moment (t1) et une deuxième résistance complexe (Z2) pouvant être mesurée à un deuxième moment (t2) postérieur au premier moment ; un degré de maturation ou la progression de la division cellulaire de l'ovocyte (Ez) pouvant être dérivé d'un écart de la partie réelle et/ou imaginaire de la première résistance complexe mesurée (Z1) et de la seconde résistance complexe (Z2). L'invention concerne également un système comprenant le dispositif selon l'invention et leur utilisation telle que représentée dans les illustrations.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102020214862.7A DE102020214862B4 (de) | 2020-11-26 | 2020-11-26 | System und Vorrichtung zur Charakterisierung von Veränderungen des Reifungsvorgangs einer Eizelle, sowie deren Verwendung |
DE102020214862.7 | 2020-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022112460A1 true WO2022112460A1 (fr) | 2022-06-02 |
Family
ID=78822078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/083078 WO2022112460A1 (fr) | 2020-11-26 | 2021-11-26 | Système et dispositif pour caractériser des changements dans le processus de maturation d'un ovocyte, et leur utilisation |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102020214862B4 (fr) |
WO (1) | WO2022112460A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001088087A2 (fr) * | 2000-05-12 | 2001-11-22 | The Board Of Trustees Of The University Of Illinois | Evaluation biologique, analyse et manipulation d'ovocytes et/ou d'embryons dans un canal microfluidique |
US20040168912A1 (en) * | 2000-02-11 | 2004-09-02 | James Klemic | Planar patch clamp electrodes |
WO2012094956A1 (fr) | 2011-01-13 | 2012-07-19 | Capitalbio Corporation | Dispositif microfluidique et son utilisation pour le positionnement de cellules ou d'organismes |
US20160257918A1 (en) * | 2015-03-04 | 2016-09-08 | Berkeley Lights, Inc. | Generation and Selection of Embryos in Vitro |
WO2020077244A1 (fr) * | 2018-10-11 | 2020-04-16 | Yale University | Procédés d'évaluation de la viabilité cellulaire et de perforation de membrane cellulaire |
-
2020
- 2020-11-26 DE DE102020214862.7A patent/DE102020214862B4/de active Active
-
2021
- 2021-11-26 WO PCT/EP2021/083078 patent/WO2022112460A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040168912A1 (en) * | 2000-02-11 | 2004-09-02 | James Klemic | Planar patch clamp electrodes |
WO2001088087A2 (fr) * | 2000-05-12 | 2001-11-22 | The Board Of Trustees Of The University Of Illinois | Evaluation biologique, analyse et manipulation d'ovocytes et/ou d'embryons dans un canal microfluidique |
WO2012094956A1 (fr) | 2011-01-13 | 2012-07-19 | Capitalbio Corporation | Dispositif microfluidique et son utilisation pour le positionnement de cellules ou d'organismes |
US20160257918A1 (en) * | 2015-03-04 | 2016-09-08 | Berkeley Lights, Inc. | Generation and Selection of Embryos in Vitro |
WO2020077244A1 (fr) * | 2018-10-11 | 2020-04-16 | Yale University | Procédés d'évaluation de la viabilité cellulaire et de perforation de membrane cellulaire |
Non-Patent Citations (4)
Title |
---|
DER ARTIKEL: "The Istanbul consensus workshop on embryo assessment", HUMAN REPRODUCTION, no. 6, 2011, pages 1270 - 1283 |
DER AUTOREN AKRAM EI HASNICARLO SCHMITZKATRIN BUI-GÖBBELSPETER BRÄUNIGWILHELM JAHNEN-DECHENTUWE SCHNAKENBERG: "Electrical impedance spectroscopy of single cells in hydrodynamic traps", SENSORS AND ACTUATORS B, vol. 248, 2017, pages 419 - 429, XP029995138, DOI: 10.1016/j.snb.2017.04.019 |
EL HASNI AKRAM ET AL: "Electrical impedance spectroscopy of single cells in hydrodynamic traps", SENSORS AND ACTUATORS B: CHEMICAL, ELSEVIER BV, NL, vol. 248, 6 April 2017 (2017-04-06), pages 419 - 429, XP029995138, ISSN: 0925-4005, DOI: 10.1016/J.SNB.2017.04.019 * |
YOSHINOBU MURAYAMA ET AL: "Elasticity Measurement of Zona Pellucida Using a Micro Tactile Sensor to Evaluate Embryo Quality", JOURNAL OF MAMMALIAN OVA RESEARCH, vol. 25, no. 1, 30 April 2008 (2008-04-30), pages 8 - 16, XP055206006, ISSN: 1341-7738, DOI: 10.1274/jmor.25.8 * |
Also Published As
Publication number | Publication date |
---|---|
DE102020214862A1 (de) | 2022-06-02 |
DE102020214862B4 (de) | 2022-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Loewenstein et al. | Intercellular communication and tissue growth: I. Cancerous growth | |
DE60316044T2 (de) | Markierungsfreies verfahren zur klassifizierung und charakterisierung zellulärer ereignisse | |
DE3688330T2 (de) | Anordnung und verfahren fuer die analyse biologischer specimen. | |
Odaci et al. | Effects of prenatal exposure to a 900 MHz electromagnetic field on the dentate gyrus of rats: a stereological and histopathological study | |
Jackson | Cable analysis with the whole-cell patch clamp. Theory and experiment | |
Spence et al. | Bringing CLARITY to gray matter atrophy | |
EP3100039B1 (fr) | Dispositif de mesure de propriétés biologiques et/ou électroniques d'un échantillon ainsi que des utilisations de ceux-ci | |
Kwon et al. | Ultrastructural, molecular and functional mapping of GABAergic synapses on dendritic spines and shafts of neocortical pyramidal neurons | |
Feldman | Dendritic changes in aging rat brain: Pyramidal cell dendrite length and ultrastructure | |
DE3643263C2 (fr) | ||
Thurai et al. | Variation with age of the dielectric properties of mouse brain cerebrum | |
Huang et al. | Impedance based biosensor array for monitoring mammalian cell behavior | |
Veruki et al. | Electrical coupling and passive membrane properties of AII amacrine cells | |
DE102020214862B4 (de) | System und Vorrichtung zur Charakterisierung von Veränderungen des Reifungsvorgangs einer Eizelle, sowie deren Verwendung | |
Mitani | The reduction of calcium current associated with early differentiation of the murine embryo. | |
Clark et al. | Functional imaging in microfluidic chambers reveals sensory neuron sensitivity is differentially regulated between neuronal regions | |
EP1775586B1 (fr) | Procédé d'examen électrophysiologique d'une membrane comprenant un canal ionique | |
Loesch et al. | Stereological and allometric studies on neurons and axo-dendritic synapses in the superior cervical ganglia of rats, capybaras and horses | |
DE10002803A1 (de) | System zur internen qualitativen und quantitativen Validierung von Markerindices | |
DE102009008320A1 (de) | Verfahren und Vorrichtung zur Messung von Impedanzen biologischer Proben | |
EP2990787B1 (fr) | Procede de mesure de la fonction des thrombocytes | |
EP0979997A1 (fr) | Methode et dispositif permettant d' identifier du liquide secrete par un vivant, notamment du liquide amniotique | |
Schmittlein | Sensors and Actuators for 2D and 3D Cell Culture Models based on Oxygen Sensitive Culture Substrates | |
Bit et al. | Brain engineering mechanics for cognitive modeling | |
DE102005019191A1 (de) | Detektion der Abdichtung mittels Rauschanalyse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21819840 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21819840 Country of ref document: EP Kind code of ref document: A1 |